The Iliac/SFA/Popliteal Center

Filter Your Results




TINTIN Trial to Evaluate Combined Therapy With iVascular's Luminor DCB and iVolution BMS

September 29, 2017 -- iVascular, based in Barcelona, Spain, recently announced the initiation of the TINTIN trial, which is evaluating the combined therapy of the company…

Study Presented at CIRSE Explores Ocular Radiation Exposure and Role of Protective Eyewear

September 22, 2017 -- Gerard Goh, MBBS, FRANZCR, EBIR, and colleagues presented data at CIRSE 2017, the annual congress of the Cardiovascular and Interventional Radiological S…

Twelve-Month Ranger DCB All-Comers Registry Data Presented at CIRSE

September 17, 2017 -- Twelve-month data from an all-comers registry evaluating the Ranger drug-coated balloon (DCB) for peripheral arterial use were presented by Michael K.W. …

iVascular's Luminor 14m DCB Approved in Canada

September 21, 2017 -- iVascular S.L.U. announced that it has received the Canadian Medical Device License for the company's paclitaxel-eluting Luminor 14m peripheral ballo…

Surmodics' 0.014-Inch Low-Profile PTA Balloon Dilation Catheter Receives FDA Clearance and CE Mark Approval

September 18, 2017 -- Surmodics, Inc. announced that it has received US Food and Drug Administration 510(k) clearance and European CE Mark approval for its 0.014-inch low-prof…

Biotronik Studies Investigate Efficacy of Minimizing Metal Burden in SFA Therapy

September 18, 2017 -- Biotronik announced that data from various Biotronik studies demonstrating that reducing metal burden in superficial femoral artery (SFA) therapy could e…

MAJESTIC Data Shows Long-Term Freedom From Revascularization With Boston Scientific's Eluvia Stent System

September 18, 2017 -- Boston Scientific Corporation announced that the 3-year results from the MAJESTIC trial for the company's Eluvia paclitaxel-eluting vascular stent sy…

Efficacy Data Presented for iVascular’s Luminor DCB

September 18, 2017 -- iVascular SLU announced that the efficacy of the company's Luminor drug-coated balloon (DCB) in patients with peripheral arterial disease (PAD) was d…




Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.